Achievements
Press Releases
2008
Thar Process’s Alternative Energy Division was awarded a $2 million grant by the National Institute of Standards and Technology (NIST) Alternative Technology Program (ATP) for the development of a novel biodiesel technology that reduces that use of toxic substances and offers a clean, continuous, and economically viable production process.
2007
Thar Process designed, built and commissioned the 2nd GMP plant for a pharmaceutical industry in the United States.
Thar Process built and commissioned the world’s largest industrial-scale supercritical chromatography system, SFC-600. The system is being used in Malaysia to separate and purify micro nutrients from palm oil.
2006
We developed the technology and built the first pilot-plant to offer polymorph screening capabilities under high pressure.
Thar Process built and commissioned the first ever process SFE system in Turkey (2x300L)
2005
Thar Process’s Microsystems Division successfully completed an ATP project that resulted in the development in new technologies in the design of CO2 cooling systems for computers, medical devices, and other microelectronics.
Thar Process built and commissioned an industrial scale counter-current SFE extraction system for purification of tocopherols from deodorized distillate in South Korea.
Thar Process developed the first commercially viable alternative technology for the de-oiling of crude lecithin. We designed, built and commissioned a plant that uses supercritical CO2 rather than acetone in the de-oiling process.
2002
Thar Process’s Microsystems Division was awarded a $2 million grant by the National Institute of Standards and Technology (NIST) Alternative Technology Program (ATP) for groundbreaking R&D in microelectronics technology: “A novel vapor compression system utilizing carbon dioxide”.
2000
We designed and built the first GMP plant in the United States.
FDA Validates Operation of GMP Plant
Built by Thar Process
June 17, 2008
Pittsburgh, PA - The U.S. Food and Drug Administration (FDA) has fully validated a GMP manufacturing process using a supercritical fluid extraction plant designed and built by Thar Process, Inc. With the FDA validation in hand, the U.S.-based pharmaceutical manufacturer has been able to fully implement a unique manufacturing process that capitalizes on the improved efficiency and reduced use of toxic solvents associated with supercritical fluid technology.
This plant is the second GMP certified supercritical fluid extraction plant that Thar Process has designed and built in the US. It is used in a proprietary pharmaceutical manufacturing process. The unique design incorporates an innovative mechanical stirring mechanism into the extraction vessel that is leak free at high pressures and temperatures. This stirring mechanism allows for homogenous mixing with a stable, wobble-free operation.
Our parent company, Thar Technologies is now a name brand in supercritical fluids and has various awards, including 2002 Small Business Exporter of the Year, Top 100 Fastest Growing Companies, and Top 25 Environmental Companies.
